0001209191-15-086507.txt : 20151222
0001209191-15-086507.hdr.sgml : 20151222
20151222101147
ACCESSION NUMBER: 0001209191-15-086507
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151221
FILED AS OF DATE: 20151222
DATE AS OF CHANGE: 20151222
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 151301086
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-12-21
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-12-21
4
M
0
10400
35.64
A
275684
D
Common Stock
2015-12-21
4
S
0
2300
117.93
D
273384
D
Common Stock
2015-12-21
4
S
0
3400
118.94
D
269984
D
Common Stock
2015-12-21
4
S
0
4100
120.07
D
265884
D
Common Stock
2015-12-21
4
S
0
600
120.65
D
265284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock held in trust
Stock Option (right to buy)
35.64
2015-12-21
4
M
0
10400
0.00
D
2016-02-01
Common Stock
10400
52800
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $117.93 (range $117.42 to $118.37).
Open market sales reported on this line occurred at a weighted average price of $118.94 (range $118.44 to $119.34).
Open market sales reported on this line occurred at a weighted average price of $120.07 (range $119.50 to $120.46).
Open market sales reported on this line occurred at a weighted average price of $120.65 (range $120.56 to $120.67).
Fully vested.
Omar White, Attorney-In-Fact
2015-12-22